The Medical Letter on Drugs and Therapeutics
November 18, 2019
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Cannabis and Cannabinoids
November 18, 2019 (Issue: 1585)Cannabis (marijuana) contains more than 60 pharmacologically active cannabinoids; delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best known. THC is the main psychoactive constituent of cannabis. CBD, unlike THC, does not produce...more
- S Patel et al. What we do (and don't) know about the health effects of cannabis and whether marijuana is medicine. Ann Intern Med 2017; 166:747.
- National Academies of Sciences, Engineering, and Medicine 2017. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press. Available at: http://bit.ly/34I1pkm. Accessed November 7, 2019.
- National Conference of State Legislatures. State medical marijuana laws. Available at: http://bit.ly/2NOJTnY. Accessed November 7, 2019.
- A Mead. Legal and regulatory issues governing cannabis and cannabis-derived products in the United States. Frontiers in Plant Science 2019; 10:1.
- HJ VanDolah et al. Clinician's guide to cannabidiol and hemp oils. Mayo Clin Proc 2019; 94:1840.
- MO Bonn-Miller et al. Labeling accuracy of cannabidiol extracts sold online. JAMA 2017; 318:1708.
- LM Dryburgh et al. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. Br J Clin Pharmacol 2018; 84:2468.
- PJ Hesketh et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2017; 35: 3240.
- G Wilkie et al. Medical marijuana use in oncology: a review. JAMA Oncol 2016; 2:670.
- PF Whiting et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313:2456.
- MH Andreae et al. Inhaled cannabis for chronic neuropathic pain: an individual patient data meta-analysis. J Pain 2015; 16: 1221.
- SM Nugent et al. The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review. Ann Intern Med 2017; 167:319.
- A Blake et al. A selective review of medical cannabis in cancer pain management. Ann Palliat Med 2017; 6(Suppl 2):S215.
- FDA Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. August 31, 2016. Available at: www.fda.gov. Accessed November 7, 2019.
- M O'Connell et al. Medical cannabis: effects on opioid and benzodiazepine requirements for pain control. Ann Pharmacother 2019; 53:1081.
- BS Koppel et al. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014; 82:1556.
- S Nielsen et al. The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews. Curr Neurol Neurosci Rep 2018; 18:8.
- A Feinstein et al. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis. Brain 2019; 142:2800.
- Cannabidiol (Epidiolex) for epilepsy. Med Lett Drugs Ther 2018; 60:182.
- O Devinsky et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol 2016; 15:270.
- X Sun et al. Marijuana for glaucoma: a recipe for disaster or treatment? Yale J Biol Med 2015; 88:265.
- N Black et al. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry 2019 October 28 (epub).
- TS Kafil et al. Cannabis for the treatment of Crohn's disease. Cochrane Database Syst Rev. 2018; 11:CD012853.
- ND Volkow et al. Adverse health effects of marijuana use. N Engl J Med 2014; 370: 2219.
- ST Wilkinson et al. Marijuana legalization: impact on physicians and public health. Annu Rev Med 2016; 67:453.
- JR Richards et al. Unintentional cannabis ingestion in children: a systematic review. J Pediatr 2017; 190:142.
- FDA. Statement on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products. August 30, 2019. Available at: http://bit.ly/2pUxEOy. Accessed November 7, 2019.
- SR Baldassarri et al. Vaping—seeking clarity in a time of uncertainty. JAMA 2019 November 7 (epub).
- SA Ryan et al. Marijuana use during pregnancy and breastfeeding: implications for neonatal and childhood outcomes. Pediatrics 2018; 142:e20181889.
- The American College of Obstetricians and Gynecologists. Committee Opinion Summary No. 722: Marijuana use during pregnancy and lactation. Obstet Gynecol 2017; 130:931.
- FDA. What you should know about using cannabis, including CBD, when pregnant or breastfeeding. Available at: http://bit.ly/32pRnDg. Accessed November 7, 2019.
- RL Hartman et al. Controlled cannabis vaporizer administration: blood and plasma cannabinoids with and without alcohol. Clin Chem 2015; 61:850.
- Inhibitors and inducers of CYP enzymes and P-glycoprotein. Med Lett Drugs Ther 2019 September 20 (epub). Available at: medicalletter.org/downloads/CYP_PGP_Tables.pdf.
- CDC. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. Available at: http://bit.ly/2qoQo9i. Accessed November 18, 2019.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.